We are live on ! Find out more

Medical Distribution
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MCK icon
1
McKesson
MCK
$112B
$112B $964.35 0.28%
COR icon
2
Cencora
COR
$62.1B
$62.1B $325.61 0.07%
CAH icon
3
Cardinal Health
CAH
$56.8B
$56.8B $245.32 0.46%
HSIC icon
4
Henry Schein
HSIC
$9.5B
$9.5B $85.30 1.25%
AHG icon
5
Akso Health Group
AHG
$1.14B
$1.14B $1.33 5.67%
FOCL icon
6
EDAP TMS S.A.
FOCL
$209M
$209M $4.42 7.28%
YI icon
7
111 Inc
YI
$26.4M
$26.4M $3 0%
COSM icon
8
Cosmos Holdings
COSM
$25.3M
$25.3M $0.2515 6.57%
ACH icon
9
Accendra Health
ACH
$16.9M
$16.9M $0.2197 8.17%
MEDS icon
10
DataMeds AI
MEDS
$9.9M
$9.9M $2.20 6.8%
HKPD icon
11
Cellyan Biotechnology
HKPD
$5.65M
$5.65M $2.29 7.01%

Medical Distribution Stocks at a Glance

Medical distributors supply drugs, instruments, and healthcare products to pharmacies, hospitals, and clinics. Pennies of margin on huge volumes make scale and logistics efficiency decisive, with steady demand offset by drug-pricing and contract-renewal pressure.

There are 11 Medical Distribution industry stocks tracked by Wall St. Rank, worth a combined $242B.

The largest by market cap are McKesson (MCK) at $112B, Cencora (COR) at $62.1B and Cardinal Health (CAH) at $56.8B.

Among institutional investors, Cardinal Health (CAH) drew the most net new fund positions in Q2 2026: 168 funds opened new positions, taking total fund holders up 66 (4.6%) quarter-over-quarter.

  • Combined market cap: $242B across 11 stocks.
  • Largest constituent: McKesson (MCK), $112B market cap.
  • Most net new fund positions in Q2 2026: Cardinal Health (CAH), +66 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.